Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 224 entries
Sorted by: Best Match Show Resources per page
Challenges in the diagnosis and treatment of depression in autism spectrum disorders across the lifespan.

Dialogues in clinical neuroscience

Chandrasekhar T, Sikich L.
PMID: 26246795
Dialogues Clin Neurosci. 2015 Jun;17(2):219-27.

Diagnosis and treatment of comorbid neuropsychiatric illness is often a secondary focus of treatment in individuals with autism spectrum disorder (ASD), given that substantial impairment may be caused by core symptoms of ASD itself. However, psychiatric comorbidities, including depressive...

Obsessive-compulsive spectrum disorders.

Dialogues in clinical neuroscience

Allen A, King A, Hollander E.
PMID: 22033547
Dialogues Clin Neurosci. 2003 Sep;5(3):259-71.

The obsessive-compulsive spectrum is an important concept referring to a number of disorders drawn from several diagnostic categories that share core obsessive-compulsive features. These disorders can be grouped by the focus of their symptoms: bodily preoccupation, impulse control, or...

Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder.

Dialogues in clinical neuroscience

Alexander GE.
PMID: 22033559
Dialogues Clin Neurosci. 2004 Sep;6(3):259-80.

Parkinson's disease (PD) is the second most common movement disorder. The characteristic motor impairments - bradykinesia, rigidity, and resting tremor - result from degenerative loss of midbrain dopamine (DA) neurons in the substantia nigra, and are responsive to symptomatic...

Psychosis in children: diagnosis and treatment.

Dialogues in clinical neuroscience

Courvoisie H, Labellarte MJ, Riddle MA.
PMID: 22033588
Dialogues Clin Neurosci. 2001 Jun;3(2):79-92.

The diagnosis of childhood psychosis raises a host of unresolved problems, despite the Diagnostic and Statistical Manual Of Mental Disorders, 4th edition, Text Revision (DSM-IV-TR) giving identical symptoms and definitions for children, adolescents, and adults. The fantasy lives of...

Cellular plasticity and resilience and the pathophysiology of severe mood disorders.

Dialogues in clinical neuroscience

Charney DS, Dejesus G, Manji HK.
PMID: 22033657
Dialogues Clin Neurosci. 2004 Jun;6(2):217-25.

Recent advances in the identification of the neural circuits, neurochemicals, and signal transduction mechanisms involved in the pathophysiology and treatment of mood disorders have led to much progress toward understanding the roles of genetic factors and psychosocial stressors. The...

Diagnosis and treatment of sleep disorders: a brief review for clinicians.

Dialogues in clinical neuroscience

Abad VC, Guilleminault C.
PMID: 22033666
Dialogues Clin Neurosci. 2003 Dec;5(4):371-88.

Sleep disorders encompass a wide spectrum of diseases with significant individual health consequences and high economic costs to society. To facilitate the diagnosis and treatment of sleep disorders, this review provides a framework using the International Classification of Sleep...

A social interaction model for war traumatization Self-processes and postwar recovery in Bosnia in subjects with PTSD and other psychological disorders.

Dialogues in clinical neuroscience

Butollo WH.
PMID: 22033669
Dialogues Clin Neurosci. 2000 Mar;2(1):71-81.

Traumatization of self-processes as a consequence of acts of war is not only determined by the content and number of traumatic experiences, but also, to a large extent by factors related to posttraumatic socioeconomic, environmental, and psychosocial interactions, À...

Violence in schizophrenia.

Dialogues in clinical neuroscience

Arango C.
PMID: 22033704
Dialogues Clin Neurosci. 2000 Dec;2(4):392-3.

No abstract available.

Optimizing dosing in atypical neuroleptic monotherapy.

Dialogues in clinical neuroscience

Trémeau F, Citrome L.
PMID: 22033705
Dialogues Clin Neurosci. 2002 Dec;4(4):438-43.

ATYPICAL NEUROLEPTICS HAVE BECOME THE FIRST LINE OF TREATMENT FOR PSYCHOTIC DISORDERS, BUT SOME QUESTIONS REMAIN: what are their optimal dosages and is more medication more efficacious? For clozapine, it is recommended to aim for a plasma level above...

Historical aspects of anxiety.

Dialogues in clinical neuroscience

Klein DF.
PMID: 22033777
Dialogues Clin Neurosci. 2002 Sep;4(3):295-304.

"Anxiety" is a key term for behavioral, psychoanalytic, neuroendocrine, and psychopharmacological observations and theories. Commenting on its historical aspects is difficult, since history is properly a study of primary data. Unfortunately, much clinical anecdote does not correspond to factual...

The role of substance P in depression: therapeutic implications.

Dialogues in clinical neuroscience

Schwarz MJ, Ackenheil M.
PMID: 22033776
Dialogues Clin Neurosci. 2002 Mar;4(1):21-9.

Substance P (for "powder"), identified as a gut tachykinin in 1931 and involved in the control of multiple other autonomic functions, notably pain transmission, is the focus of intense fundamental and clinical psychiatric research as a central neurotransmitter, neuromodulator,...

Concepts in human biological rhythms.

Dialogues in clinical neuroscience

Reinberg A, Ashkenazi I.
PMID: 22033796
Dialogues Clin Neurosci. 2003 Dec;5(4):327-42.

Biological rhythms and their temporal organization are adaptive phenomena to periodic changes in environmental factors linked to the earth's rotation on its axis and around the sun. Experimental data from the plant and animal kingdoms have led to many...

Showing 1 to 12 of 224 entries